The Iowa Board of Regents will recognize six outstanding University of Iowa faculty members for their extraordinary contributions and sustained record of distinction in teaching, scholarship, and service.

An existing drug currently used to treat glaucoma, altitude sickness, and seizures may also have potential for preventing relapse in opioid use disorder, according to a new study by researchers at University of Iowa Health Care. The UI researchers led by John Wemmie, MD, PhD, focused on the drug known as acetazolamide (AZD) because it blocks the activity of a brain enzyme called carbonic…

Michelle Howard, PhD, has always been interested in pediatric cancers, but she credits her patients, not her profession, for pushing her and her research team toward the next innovative solution.

Tyler Draayer knew he could count on the University of Iowa to prepare him for a successful medical career.

It was a blustery March morning in 2005 when Stacy Van Gorp paused outside the college classroom in Cedar Falls, Iowa, where she was about to teach. The twins she was carrying — usually active and insistent — had gone quiet.

Lab scientist Dave Buhr gives back to his alma mater to revitalize the major and address a national workforce shortage in the field.

Rural health care careers often start with a personal connection, and for Alec Marticoff, the decision to pursue medicine started at home. Growing up in Readlyn, Iowa, Marticoff saw the impact of compassionate health care when his sister Brandi was diagnosed with Type 1 diabetes. Helping his family manage her condition sparked a lasting passion for medicine and a career dedicated to helping…

In a new study published in Science, Ksenia Krupina, PhD, working in the laboratory of Don Cleveland, PhD, at University of California San Diego, has identified a long-searched-for culprit: N4BP2, a nuclease capable of breaking chromosomes inside cancer cells. Krupina will join University of Iowa Health Care Holden Comprehensive Cancer Center in February 2026 as an assistant professor of…

A glow-germ experiment at age 11 sparked MaryTherese (MT) Gehrmann’s fascination with science.

Since 2013, the NIH NeuroBioBank (NBB) has catalyzed scientific discovery through the centralization of resources aimed at the collection and distribution of human post-mortem brain tissue to understand conditions of the nervous system.